A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders-Reference-Cited by-同舟云学术

A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders

Published:2017-06-12 Issue:6 Volume:12 Page:e0179247
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jeon Sang Won,Han Changsu^ORCID,Ko Young-Hoon,Yoon Seoyoung,Pae Chi-Un,Choi Joonho,Kim Jae-Min,Yoon Ho-Kyoung,Lee Hoseon,Patkar Ashwin A.,Zimmerman Mark

Funder

Korea Health Industry Development Institute

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder;M Zimmerman;Am J Psychiatry,2000

2. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study;TK Melartin;J Clin Psychiatry,2002

3. Remission and relapse in major depression: a two-year prospective follow-up study;R Ramana;Psychol Med,1995

4. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking;PP Roy-Byrne;Br J Psychiatry,2000

5. Anxious depressions. Clinical, family history, and naturalistic outcome—comparisons with panic and major depressive disorders;C VanValkenburg;J Affect Disord,1984

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex Differences in the Association between Prolonged Sitting Time and Anxiety Prevalence among Korean Adults;Brain Sciences;2024-07-20

2. Exploring the Association between Elevated Anxiety Symptoms and Low Skeletal Muscle Mass among Asymptomatic Adults: A Population-Based Study in Republic of Korea;Brain Sciences;2024-04-28

3. Characteristics of Korean Employees Without Depression but Having Suicidal Ideation;Psychiatry Investigation;2023-07-25

4. Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial;Clinical Psychopharmacology and Neuroscience;2023-02-28

5. Association between coronavirus disease 2019-related workplace interventions and prevalence of depression and anxiety;Annals of Occupational and Environmental Medicine;2022